Yozo Sato

1.9k total citations
114 papers, 1.3k citations indexed

About

Yozo Sato is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Hepatology. According to data from OpenAlex, Yozo Sato has authored 114 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Pulmonary and Respiratory Medicine, 45 papers in Surgery and 44 papers in Hepatology. Recurrent topics in Yozo Sato's work include Hepatocellular Carcinoma Treatment and Prognosis (42 papers), Colorectal Cancer Treatments and Studies (16 papers) and Lung Cancer Diagnosis and Treatment (11 papers). Yozo Sato is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (42 papers), Colorectal Cancer Treatments and Studies (16 papers) and Lung Cancer Diagnosis and Treatment (11 papers). Yozo Sato collaborates with scholars based in Japan, United States and Germany. Yozo Sato's co-authors include Yoshitaka Inaba, Hidekazu Yamaura, Yasuaki Arai, Miyuki Sone, Kei Muro, Hiroaki Onaya, Takaaki Hasegawa, Hirokazu Watanabe, Takeshi Aramaki and Takashi Ura and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Radiology.

In The Last Decade

Yozo Sato

106 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yozo Sato Japan	19	589	442	413	406	193	114	1.3k
Vittorio Pedicini Italy	19	450 0.8×	546 1.2×	314 0.8×	453 1.1×	137 0.7×	65	1.3k
Hsuan‐Chih Hsu Taiwan	23	737 1.3×	600 1.4×	460 1.1×	288 0.7×	193 1.0×	46	1.7k
Byung Gil Choi South Korea	23	422 0.7×	608 1.4×	189 0.5×	321 0.8×	265 1.4×	92	1.7k
Danny Yakoub United States	21	712 1.2×	860 1.9×	535 1.3×	280 0.7×	87 0.5×	81	1.5k
Marcos V. Perini Australia	18	336 0.6×	567 1.3×	477 1.2×	424 1.0×	52 0.3×	97	1.2k
Pierre‐Jean Valette France	18	433 0.7×	735 1.7×	419 1.0×	239 0.6×	146 0.8×	66	1.3k
Eric J. van der Jagt Netherlands	26	673 1.1×	1.0k 2.3×	289 0.7×	546 1.3×	195 1.0×	60	1.9k
S Chagnon France	19	483 0.8×	534 1.2×	606 1.5×	458 1.1×	156 0.8×	74	1.6k
Ellen Chung United States	22	337 0.6×	515 1.2×	264 0.6×	270 0.7×	87 0.5×	43	1.6k
Chandana Lall United States	20	290 0.5×	473 1.1×	199 0.5×	197 0.5×	288 1.5×	67	1.1k

Countries citing papers authored by Yozo Sato

Since Specialization

Citations

This map shows the geographic impact of Yozo Sato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yozo Sato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yozo Sato more than expected).

Fields of papers citing papers by Yozo Sato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yozo Sato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yozo Sato. The network helps show where Yozo Sato may publish in the future.

Co-authorship network of co-authors of Yozo Sato

This figure shows the co-authorship network connecting the top 25 collaborators of Yozo Sato. A scholar is included among the top collaborators of Yozo Sato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yozo Sato. Yozo Sato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kodama, Yoshihisa, Michihisa Moriguchi, Yoshitaka Inaba, et al.. (2025). Protocol of the IMPACT study: randomized, multicenter, phase 3 study evaluating the efficacy of immunotherapy (Atezolizumab) plus anti-VEGF therapy (Bevacizumab) in combination with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma. BMC Cancer. 25(1). 434–434. 3 indexed citations

Sato, Yozo, Kiyoshi Matsueda, & Yoshitaka Inaba. (2024). Basic Techniques and Technical Tips for Ultrasound-guided Needle Puncture. PubMed. 9(3). 80–85.

Inaba, Yoshitaka, et al.. (2024). Treatment of hepatocellular carcinoma with a portal vein tumor thrombus and pulmonary metastases of rectal cancer with microsatellite stability using atezolizumab plus bevacizumab. Clinical Journal of Gastroenterology. 17(2). 286–291.

Sato, Yozo, et al.. (2024). Successful ureteral stent placement with rendezvous technique for ureteral obstruction after urinary diversion: A case report. SHILAP Revista de lepidopterología. 19(11). 4908–4911.

Miyanaga, Akihiko, Takehiro Tozuka, Yozo Sato, et al.. (2023). Remarkable Clinical Response of ALK-Rearranged/TP53-Mutant Lung Adenocarcinoma with Liver Metastasis to Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel After ALK Inhibitors: A Case Report. OncoTargets and Therapy. Volume 16. 465–470. 2 indexed citations

Hasegawa, Takaaki, et al.. (2023). Clinical Outcomes of Radiofrequency Ablation Combined with Transarterial Chemoembolization Using Degradable Starch Microsphere Mixed with Mitomycin C for the Treatment of Non-hepatocellular Carcinoma Malignant Liver Tumors. PubMed. 8(1). 7–13. 1 indexed citations

Sato, Yozo, Kiyoshi Matsueda, Marie Osawa, et al.. (2022). Interventional management for postoperative arterial bleeding in gastrointestinal surgery. SHILAP Revista de lepidopterología. 11(4). 179–185.

Sato, Yozo, Akimasa Sekine, Eri Hagiwara, et al.. (2021). Successful treatment with afatinib following the failure of osimertinib rechallenge with osimertinib-induced interstitial lung disease: A case report. Respiratory Medicine Case Reports. 33. 101450–101450. 6 indexed citations

Hasegawa, Takaaki, Haruyuki Takaki, Hiroshi Kodama, et al.. (2020). Three-year Survival Rate after Radiofrequency Ablation for Surgically Resectable Colorectal Lung Metastases: A Prospective Multicenter Study. Radiology. 294(3). 686–695. 47 indexed citations

10.

Oda, T., Akimasa Sekine, Midori Sato, et al.. (2020). Five cases of BRAF V600E-mutant lung adenocarcinoma with high expression of programmed death ligand 1. Respiratory Medicine Case Reports. 30. 101071–101071. 3 indexed citations

11.

Misawa, Kazunari, Yozo Sato, Yuichi Ito, et al.. (2020). Gastroduodenal artery pseudoaneurysm hemorrhage 1 year after laparoscopic distal gastrectomy: a case report. SHILAP Revista de lepidopterología. 6(1). 38–38. 2 indexed citations

12.

Kudo, Masatoshi, Michihisa Moriguchi, Kazushi Numata, et al.. (2017). S-1 versus placebo in patients with sorafenib-refractory advanced hepatocellular carcinoma (S-CUBE): a randomised, double-blind, multicentre, phase 3 trial. The Lancet. Gastroenterology & hepatology. 2(6). 407–417. 42 indexed citations

13.

Miyazaki, Masaya, Toshihiro Iguchi, Haruyuki Takaki, et al.. (2016). Ablation protocols and ancillary procedures in tumor ablation therapy: consensus from Japanese experts. Japanese Journal of Radiology. 34(9). 647–656. 21 indexed citations

14.

Masada, Tetsuya, Toshihiro Tanaka, Hiroshi Sakaguchi, et al.. (2014). Coils versus Gelatin Particles with or without Intraarterial Antibiotics for Partial Splenic Embolization: A Comparative Evaluation. Journal of Vascular and Interventional Radiology. 25(6). 852–858. 12 indexed citations

15.

Inaba, Yoshitaka, Hidekazu Yamaura, Yozo Sato, et al.. (2013). Percutaneous Radiologic Gastrostomy in Patients with Malignant Pharyngoesophageal Obstruction. Japanese Journal of Clinical Oncology. 43(7). 713–718. 12 indexed citations

16.

Sato, Yozo, Hirokazu Watanabe, Miyuki Sone, et al.. (2012). Tumor response evaluation criteria for HCC (hepatocellular carcinoma) treated using TACE (transcatheter arterial chemoembolization): RECIST (response evaluation criteria in solid tumors) version 1.1 and mRECIST (modified RECIST): JIVROSG-0602. Upsala Journal of Medical Sciences. 118(1). 16–22. 55 indexed citations

17.

Shitara, Kohei, Takashi Ura, Keitaro Matsuo, et al.. (2011). Sensitivity to previous irinotecan treatment does not predict the efficacy of combination chemotherapy with cetuximab plus irinotecan for wild-type KRAS metastatic colorectal cancer. European Journal of Cancer. 47(18). 2673–2680. 1 indexed citations

18.

Shitara, Kohei, Tomoya Yokota, Daisuke Takahari, et al.. (2010). Cetuximab plus FOLFOX for Patients with Metastatic Colorectal Cancer with Poor Performance Status and/or Severe Tumor-Related Complications. Case Reports in Oncology. 3(2). 282–286. 4 indexed citations

19.

Shitara, Kohei, Keitaro Matsuo, Daisuke Takahari, et al.. (2009). Neutropaenia as a prognostic factor in metastatic colorectal cancer patients undergoing chemotherapy with first-line FOLFOX. European Journal of Cancer. 45(10). 1757–1763. 70 indexed citations

20.

Yamaura, Hidekazu, et al.. (2007). Bilateral Pneumothorax after Unilateral Transthoracic Puncture. Journal of Vascular and Interventional Radiology. 18(6). 793–795. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact